Find an abstract and a link to most of the publications produced by Nordic Bioscience
OBJECTIVES: Macrophages possess widespread pro-inflammatory, destructive, and remodelling capabilities that can critically contribute to acute and chronic diseases, such as rheumatoid arthritis (RA). Continuous monitoring and measurement of selective counteraction of macrophage activity in patients ...
November 7, 2018
Journal:
Clin Exp Rheumatol.
Author:
Mortensen JH, Guo X, De Los Reyes M, Dziegiel MH, Bay Jensen AC, White WI
OBJECTIVES:Targeting the granulocyte-macrophage colony-stimulating factor (GM-CSF) pathway holds great potential in the treatment of inflammatory diseases. Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody, has demonstrated clinical efficacy in RA. Our current study aimed to elucidate mech...
October 23, 2017
Journal:
Rheumatology (Oxford)
Author:
Guo X, Higgs BW, Bay-Jensen AC, Wu Y, Karsdal MA, Kuziora M, Godwood A, Close D, Ryan PC, Roskos LK, White WI
Background: Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and loss of lung tissue mainly consisting of extracellular matrix (ECM). Three of the main ECM components are type I collagen, the main constituent in the interstitial matrix, type VI collagen, and elast...
January 19, 2017
Journal:
Respir Res.
Author:
Bihlet AR, Karsdal MA, Leeming DJ, Roberts M, Bowler R, White WI, Bülow Sand JM
Type I IFNs are implicated in the pathophysiology of systemic sclerosis (SSc). Recently, a Phase I open-label trial was conducted with an anti-IFNAR1 receptor antibody (anifrolumab) in adult SSc patients. In this study, we aim to assess the downstream effects of anifrolumab and elucidate the role of...
October 1, 2015
Journal:
J Invest Dermatol
Author:
Guo X, Higgs BW, Bay-Jensen AC, Karsdal MA, Yao Y, Roskos LK, White WI
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.